Covid-19: India begins testing possible cure on patients at PGI Chandigarh
Covid-19: India begins testing possible cure on patients at PGI Chandigarh

India's premier scientific research body announced Covid drug trial.

CSIR-Indian Institute of Integrative Medicine's director spoke on the trials.

Sepsivac, a new drug used against sepsis, being tried on Covid patients.

There are going to be 3 different kinds of trials on various sets of patients.

With the global death toll over 2 lakh, there's a race to create a vaccine or cure.

Watch the video for more.